About 1 in 8 adults in the United States has used a GLP-1 drug like Ozempic or Mounjaro at some point in their life.
(Reuters) - About one in eight adults have taken a drug belonging to the GLP-1 class of medications for weight loss and ...
A KFF poll also suggests half of the respondents who had tried these weight loss meds no longer took them, with many ...
A poll from the health policy nonprofit KFF found that 1 in 8 adults say they’ve taken a GLP-1 agonist, the obesity and ...
A new KFF health tracking survey found that one in eight U.S. adults have taken Ozempic or a similar GLP-1 drug at some point ...
The number of adolescents and young adults prescribed a glucagon-like peptide-1 (GLP-1) receptor agonist increased nearly 600 ...
KFF poll results suggest about 12 percent of adults in the U.S. have tried a GLP-1 drug like Ozempic to manage chronic health ...
The number of American teens and young adults who've been prescribed one of the new GLP-1 weight-loss drugs soared nearly ...
(Reuters) – About one in eight adults have taken a drug belonging to the GLP-1 class of medications for weight loss and related conditions, a poll by Kaiser Family Foundation (KFF) showed on Friday.
I’M MINDY BASARA IN TODAY’S MEDICAL ALERT, WEIGHT LOSS AND DIABETES DRUGS LIKE OZEMPIC WEGOVY AND ZYBAN ARE ALL THE RAGE RIGHT NOW. AND TO HELP BETTER UNDERSTAND WHAT’S HAPPENING WITH THESE ...